Coagulation Factor X, Human Plasma

Clotting activity is determined by comparison to a standard curve produced using normal pooled human plasma

single band by SDS-PAGE

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

Toxicity: Standard Handling (A)

Native coagulation factor X from human plasma. In the coagulation cascade, Factor X is converted to Factor Xa, the enzyme that converts prothrombin to thrombin by either the extrinsic or intrinsic pathway. Sold on the basis of units where one unit equals the amount of factor X in 1 ml pooled human plasma (100 units = 0.8 mg). In the coagulation cascade, Factor X is converted to Factor Xa, the enzyme which converts prothrombin to thrombin by either the extrinsic or intrinsic pathway.

Please refer to vial label for lot-specific concentration.

In 100 mM NaCl, 20 mM Tris-HCl, 1 mM benzamidine, pH 7.4.

Following initial thaw, aliquot and freeze (-70°C).

Prepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany